Clinical and hemodynamic effect of endothelin receptor antagonists in eisenmenger syndrome

• Egile Nagusiak: Emir Yonas (Egilea), Raymond Pranata (Egilea), Muhammad Yamin (Egilea), Nuvi Nusarintowati (Egilea), Siti Elkana Nauli (Egilea), Hafil Budianto Abdulgani (Egilea), Bambang Budi Siswanto (Egilea)
• Formatua: Liburua
• Argitaratua: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: Endothelin receptor antagonists (ERAs) are widely accepted as a specific treatment for pulmonary arterial hypertension. Unfortunately, consensus and recommendations are lacking for the treatment of patients who suffer from pulmonary arterial hypertension and congenital heart disease, i...